Results of two diabetes studies announced by Prime Therapeutics
Studies found that insulin usage and costs increased; ER visits related to hypoglycemia infrequent. Read More »
Studies found that insulin usage and costs increased; ER visits related to hypoglycemia infrequent. Read More »
Two studies were presented at the Academy of Managed Care Pharmacy meeting this week. Read More »
Prime Therapeutics announced last week that it will start the management of pharmacy benefits for Blue Cross & Blue Shield of Rhode Island (BCBSRI) beginning on Jan 1, 2017. Read More »
Prime Therapeutics LLC, a company that manages pharmacy benefits and serves more than 26 million people, recently named Jonathan B. Gavras, M.D., as its new chief medical officer (CMO). Read More »
Upsher-Smith Laboratories Inc. and the National Alliance of State Pharmacy Associations (NASPA) have partnered to honor 43 pharmacists from across the United States with the 2015 NASPA Excellence in Innovation Award. Read More »
Georgia Eddleman Little has been named the new vice president and chief customer experience officer at Prime Therapeutics. Read More »
Pharmacy benefit manager Prime Therapeutics recently added two FDA-approved cholesterol lowering drugs to its preferred national drug list. Read More »
Prime Therapeutics selected Scott Fries, its senior vice president of Government Programs, as the company's chief operating officer. Read More »
HealthPartners recently awarded Essentia Health’s primary care and pharmacy teams with 11 awards to celebrate the organization’s commitment to revolutionizing the health care system. Read More »
Patients with high cholesterol are prescribed statins, but a recent study said about half of these patients will stop using the medication within the first year. Read More »
BioScrip Inc. today announced a multi-step plan to improve shareholder value, increase financial flexibility and position BioScrip as a pure play infusion services company focused on high-growth services. Read More »
in the July issue of the Atlantic Information Services newsletter, executives at two Blue Cross and Blue Shield Plans and a Blues-owned pharmacy-benefit manager (PBM) shared some of the strategies Blues plans are using to lessen the financial impact of generic-drug price inflation. Read More »
Career Step, an online provider of career-focused education, announced today that its online pharmacy technician training program has been granted approval by the Minnesota State Board of Pharmacy. Read More »
Qudexy XR, a treatment option for seizures, has been approved for an expanded indication that will allow it to be used In patients as young as 2 years old, drug maker Upsher-Smith said on Monday. This treatment already had been approved for patients 10 and up since June 2014. It Is primarily used as a therapeutic measure for patients prone to partial-onset or primary generalized tonic-clonic seizures. The capsules can be ground into a fine powder and sprinkled onto soft food for patients who h Read More »
A recent Prime Therapeutics, LLC study on hereditary angioedema revealed that individuals with the condition are accumulating specialty drug costs of more than $300,000 annually on average. Read More »
Service Quality Management Group (SQM), a leading North American research company, recently granted Prime Therapeutics, LLC an award for its excellence in call center practices. Read More »
OptumRX, UnitedHealth Group’s pharmacy-care services business, and Catamaran Corp., a provider of pharmacy-benefit services and technology solutions, said on Monday that they have agreed to a merger. Read More »
Pharmacy Quality Solutions (PQS) said on Monday that it will partner with Prime Therapeutics LLC to improve medication-use regimens through collaboration with prescription-drug plans and community pharmacies. "Prime's work with PQS supports our purpose in helping people get the medicine they need to feel better and live well," Scott Fries, senior vice president of government programs at Prime, said. Read More »
The $2.3 billion transaction expected to be completed by second quarter. Read More »
Prime Therapeutics, a Twin Cities-based pharmacy benefit manager, said on Monday that Ellyn Hosch has been promoted to senior vice president and chief information officer. Read More »